COMMENT
JOURNAL ARTICLE

ACP Journal Club. Review: In diabetes, ACE-Is, but not ARBs, reduce mortality and major CV events compared with placebo or active treatment

Rozalina McCoy, Steven Smith
Annals of Internal Medicine 2014 August 19, 161 (4): JC2
25133381
No abstract text is available yet for this article.

Full Text Links

Find Full Text Links for this Article

Discussion

You are not logged in. Sign Up or Log In to join the discussion.

Related Papers

ACP Journal Club. Review: ACE-Is or ARBs reduce adverse CV outcomes regardless of baseline systolic blood pressure. Vibhuti Singh Annals of Internal Medicine 2012 July 17, 157 (2): JC2-8
Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on all-cause mortality, cardiovascular deaths, and cardiovascular events in patients with diabetes mellitus: a meta-analysis. Jun Cheng, Wen Zhang, Xiaohui Zhang, Fei Han, Xiayu Li, Xuelin He, Qun Li, Jianghua Chen JAMA Internal Medicine 2014, 174 (5): 773-85
ACP Journal Club. Aliskiren increased adverse events in patients with diabetes and kidney disease who were receiving ACE inhibitors or ARBs. Peter W de Leeuw Annals of Internal Medicine 2013 March 19, 158 (6): JC7
ACP Journal Club. Review: Metformin reduces risk for CV mortality compared with other oral diabetes drugs or placebo in type 2 diabetes. Lorraine Lipscombe Annals of Internal Medicine 2009 April 21, 150 (8): JC4-8
Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension. Edmond C K Li, Balraj S Heran, James M Wright Cochrane Database of Systematic Reviews 2014 August 22, (8): CD009096
ACP Journal Club. Adding prompt revascularization to medical therapy did not reduce mortality or CV events in patients with type 2 diabetes and CAD. Paul Poirier Annals of Internal Medicine 2009 October 20, 151 (8): JC4-5
Evidence for the efficacy of ARBs across the cardiovascular continuum. Milan Gupta, George N Honos, Eric J Velazquez, Namsik Chung, Willie Oigman, Aldo P Maggioni Current Medical Research and Opinion 2010, 26 (5): 1203-18
ACP Journal Club. Review: Statins reduce mortality and major vascular events in patients with no history of CV disease. C Raina Elley Annals of Internal Medicine 2013 July 16, 159 (2): JC2
ACP Journal Club: Review: Low BP targets do not reduce mortality or CV events in hypertension. Finlay A McAlister Annals of Internal Medicine 2009 November 17, 151 (10): JC5-6-7
ACP Journal Club. Review: Intensive glucose control reduced some CV events but did not change mortality in type 2 diabetes. Lorraine L Lipscombe Annals of Internal Medicine 2009 September 15, 151 (6): JC3-6
Make the most of Read.
Download the mobile app.

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Remove bar
Read by QxMD icon Read
25133381
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"